Page 52 - பல்கலைக்கழகம் ஆஃப் லூயிஸ்வில்லி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Bullpen Report: July 23, 2021 | RotoGraphs Fantasy Baseball
fangraphs.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fangraphs.com Daily Mail and Mail on Sunday newspapers.
Friday morning Cardinal news and notes
cardchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cardchronicle.com Daily Mail and Mail on Sunday newspapers.
Kentucky, Indiana officials urge vaccine as delta variant spreads
whas11.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from whas11.com Daily Mail and Mail on Sunday newspapers.
ADVERTISEMENT
Adidas Says NCAA s High Court Loss Can t Save RICO Suit
Law360 (July 21, 2021, 7:31 PM EDT) Adidas says the NCAA s recent loss at the U.S. Supreme Court in a case over amateurism restriction does not show that athletes have a business interest in playing college basketball, rejecting an argument from a former University of Louisville recruit to revive claims for damages over how the college hoops corruption scandal tanked his college career.
The German sports and athletic apparel maker said last month s NCAA v. Alston decision never even addressed, much less undercut U.S. District Judge Joseph F. Anderson Jr. s reasoning that Brian Bowen II did not have a protectable property interest in playing college basketball.
Existing drug may be effective in treating COVID-19
A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.
The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2 in human cell cultures and in a mouse model, leading to much lower viral loads.
Researchers at UChicago s Pritzker School of Molecular Engineering (PME), working with collaborators at Argonne National Laboratory and around the world, also found that the drug could be effective against many types of coronaviruses and picornaviruses. Because of the way it inhibits replication, it has also been shown to remain effective in the face of COVID-19 variants.